FCPA Pilot Program

FCPA Pilot Program
Name	FCPA Pilot Program
Established	2016
Administering body	United States Department of Justice, U.S. Securities and Exchange Commission
Relevant law	Foreign Corrupt Practices Act of 1977
Jurisdiction	United States
Status	concluded

FCPA Pilot Program

The FCPA Pilot Program was a temporary initiative announced by the United States Department of Justice and the U.S. Securities and Exchange Commission to incentivize voluntary self-disclosure and cooperation in investigations under the Foreign Corrupt Practices Act of 1977. It sought to align prosecutorial incentives with corporate compliance reforms after high-profile enforcement actions involving multinational corporations such as Siemens AG, Boeing, Halliburton, Schlumberger, and Alstom. The program influenced settlement practices alongside seminal cases involving firms like Goldman Sachs, Och-Ziff Capital Management, Walt Disney Company, GlaxoSmithKline, and Siemens.

Overview

The Pilot Program was announced by the Criminal Division (DOJ) and coordinated with the Division of Enforcement (SEC) to offer potential declinations or reduced penalties for companies that voluntarily self-disclosed violations of the Foreign Corrupt Practices Act of 1977, fully cooperated with investigations, and timely and appropriately remediated misconduct. It followed a lineage of enforcement frameworks such as the Yates Memo, the Thompson Memorandum, and guidance documents like the Principles of Federal Prosecution of Business Organizations and complemented international anti-corruption initiatives involving the Organisation for Economic Co-operation and Development, United Nations Convention against Corruption, and enforcement by agencies such as the Serious Fraud Office (United Kingdom), Autorité des marchés financiers (France), and Public Prosecutor General (Germany). The Pilot Program intersected with policy debates sparked by major investigations into Siemens AG, Panasonic, Alstom, Siemens, Bristol-Myers Squibb, and Rolls-Royce.

Eligibility and Participation Criteria

Eligibility criteria emphasized voluntary self-disclosure, full cooperation, and timely or appropriate remediation—principles traceable to guidance from the DOJ and the SEC in cases involving Siemens AG and GlaxoSmithKline. Companies needed to demonstrate credible internal investigations, often involving outside counsel and forensic accountants such as PricewaterhouseCoopers, KPMG, Deloitte, and Ernst & Young. Participation required coordination with prosecutors from the Fraud Section (DOJ), senior trial attorneys, and SEC Enforcement staff, and often implicated cross-border coordination with enforcement authorities including the Serious Fraud Office (United Kingdom), Parquet National Financier (France), Public Prosecutor's Office (Switzerland), and Brazilian Federal Police. Factors considered included the involvement of senior executives, links to intermediaries like agents or consultants, and the scope of conduct in jurisdictions such as China, Brazil, Nigeria, India, and Mexico.

Application and Review Process

Companies seeking Pilot Program consideration typically initiated contact with the Fraud Section (DOJ) or SEC Division of Enforcement through formal disclosures supported by factual proffers, privilege waivers, and voluntary document timelines. The review process involved coordination among investigative units including the Counterintelligence Division, National Security Division (DOJ), and SEC staff attorneys, and often required engagement with international partners such as the FBI, Europol, Australian Federal Police, and the Office of the Attorney General (Canada). Prosecutors evaluated self-reporting against precedents from landmark resolutions with Siemens, Alstom, Bristol-Myers Squibb, Walmart de México, and Panasonic and applied guidelines from instruments like the Principles of Federal Prosecution of Business Organizations and the Yates Memo.

Outcomes and Remedies

Outcomes under the Pilot Program ranged from declinations with disgorgement or monitoring agreements to deferred prosecution agreements (DPAs) and non-prosecution agreements (NPAs), modeled on resolutions in cases involving Siemens AG, GlaxoSmithKline, Goldman Sachs, Odebrecht, and Rolls-Royce. Remedies frequently required enhanced compliance measures, independent compliance monitors similar to those imposed in Siemens and Alstom matters, disgorgement, civil penalties enforced by the SEC, and corporate cooperation credits that affected sentencing and fine calculations under the U.S. Sentencing Guidelines and prosecutorial charging decisions such as those in the VimpelCom and Petrobras investigations. Settlements often considered remediation steps like board-level compliance reforms, engagement of external auditors from KPMG or Ernst & Young, and remedial training programs.

Criticisms and Legal Challenges

Critics argued the Pilot Program created inconsistent incentives and uneven bargaining power between prosecutors and corporations, echoing controversies from the Thompson Memorandum, critiques by the American Bar Association, and litigation involving disclosure and privilege issues raised in cases like In re: Sealed Case and Upjohn Co. v. United States. Questions arose about waiver of attorney–client privilege, the scope of cooperation credits, and the use of independent monitors, drawing scrutiny from entities such as the Chamber of Commerce (United States), New York State Bar Association, and international commentators. Legal challenges and scholarly critiques cited experiences from high-profile actions such as Siemens and Alstom and debated the program’s conformity with prosecutorial policies set by the Office of Legal Counsel and the Attorney General of the United States.

Impact on Enforcement Practices and Compliance Programs

The Pilot Program influenced subsequent DOJ and SEC enforcement priorities, encouraging early voluntary disclosures and investment in compliance programs modeled after guidance published by the Department of Justice and the Securities and Exchange Commission. Corporate responses included expanded roles for chief compliance officers, adoption of third-party due diligence frameworks used by firms like General Electric, Chevron, ExxonMobil, Pfizer, and Novartis, and increased use of automated compliance monitoring tools from vendors such as SAP and Oracle. The program’s legacy affected international coordination on anti-corruption enforcement involving the OECD Working Group on Bribery, the International Bar Association, and regional authorities including the European Commission and National Anti-Corruption Commission (Thailand), shaping how multinational corporations approach risk assessments, internal investigations, and remediation after investigations involving intermediaries and cross-border transactions.

Category:United States federal law